Product Program year 2025 Source: CMS Open Payments

Technetium TC 99M Sestamibi

Drug Diagnostic

NDC 45548-141-10

Open in the dashboard

General payments

$427

23 payments

Research payments

$0

0 payments

Through program year 2025, $427 in general payments and $0 in research payments were reported against Technetium TC 99M Sestamibi (Diagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $362 19
2024 General $65 4

Breakdown

Who paid General payments · program years 2024–2025
  1. Jubilant DraxImage, Inc. $362 19 payments
  2. Jubilant DraxImage Inc. $65 4 payments
Top recipients General payments · program year 2025
  1. Michelle Akella Nurse Practitioner, Family · Bradenton, FL $67 19% · 5 payments
  2. Jagan Akella Cardiovascular Disease · Bradenton, FL $65 18% · 4 payments
  3. Vaqar Ali Interventional Cardiology · Jacksonville, FL $49 14% · 1 payment
  4. Ghazanfar Khadim Interventional Cardiology · Zephyrhills, FL $28 8% · 1 payment
  5. Aung Tun Cardiovascular Disease · Zephyrhills, FL $28 8% · 1 payment

The top 5 of 12 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $132 38% · 4 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $107 31% · 3 practitioners
  3. Interventional Cardiology Internal Medicine $77 22% · 2 practitioners
  4. Diagnostic Radiology Radiology $19 6% · 1 practitioner
  5. Nurse Practitioner, Adult Health Nurse Practitioner $13 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Florida $362 100% · 12 recipients

Each share is of general payments naming this product in 2025 where a state was reported.

23 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record